Sharemaestro company-news research for Tatva Chintan Pharma Chem Limited (TATVA), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NSI
India
Provisional evidence
Company news sentiment
Latest TATVA news and sentiment
Tatva Chintan Pharma Chem Limited
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
Current company news
Early balanced news score
12 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Observed headline tone66/100
→
Published 30-day score53/100
Latest source headline
Tatva Chintan Q1 net profit rises 54.8% to ₹159.81 million
scanx.trade · 26 Sep 2026 02:35
Older, less relevant and less reliable stories count for less. Confidence is shown separately.
What supports the score
12 current stories are mapped specifically to TATVA.
What limits the score
Only 2 publishers currently contribute to the measured read.
The stories agree, but freshness-weighted evidence is only 0.188.
Confidence is 26/100, below the threshold for a firm score.
53/100
News scoreEarly balanced news score
26/100
Confidencethin evidence
100%/100
Company news12 company stories
100/100
Story agreement0/100 difference
News history
Daily score and story count over 30 days
31 Aug15 Sep29 Sep
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence4
0.188 after freshness weightingSource breadth40
2 independent publishersCompany relevance100
share tied directly to this companyFreshness39
recency-weighted evidenceAgreement100
how closely stories agreePublisher mix32
less reliance on one publisherPrice and news history
Weekly price and news-score history
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
26 completed price weeks20 comparable news-score weeks
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
03 Apr30 Jun25 Sep
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
25 Sep 202651INR 1793.199951+1.3%
18 Sep 202653INR 1770.199951+10.0%
11 Sep 202651INR 1608.699951-4.0%
04 Sep 202650INR 1676.476807+3.0%
28 Aug 202650INR 1628.035278+0.8%
21 Aug 202650INR 1614.45166-5.9%
14 Aug 202650INR 1715.230103-0.1%
07 Aug 202651INR 1716.728271-4.0%
Provisional evidence
News subjects
What is shaping the score
Earnings665 stories · 42%
Market update505 stories · 42%
Capital return501 stories · 8%
Analyst action501 stories · 8%
Source mix
Where the evidence comes from
scanx.trade657 stories · 58%
Indiatimes661 stories · 8%
MarketsMojo501 stories · 8%
Value Research501 stories · 8%
valueresearchonline.com501 stories · 8%
ET Chemicals501 stories · 8%
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
04 May50 neutral29 Sep 03:48
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 29 Sep 03:48 | 52 | -1 | 24/100 (-3) | 12 (-1) | Provisional |
| 26 Sep 23:59 | 53 | +0 | 27/100 (-2) | 13 (-1) | Provisional |
| 17 Sep 23:59 | 53 | +1 | 29/100 (+2) | 14 (+1) | Provisional |
| 14 Sep 23:59 | 52 | -1 | 27/100 (-2) | 13 (+1) | Provisional |
| 13 Sep 23:59 | 53 | +2 | 29/100 (+6) | 12 (+1) | Provisional |
| 10 Sep 23:59 | 51 | -1 | 23/100 (-7) | 11 (0) | Provisional |
| 06 Sep 23:59 | 52 | +2 | 30/100 (+3) | 11 (+1) | Provisional |
| 04 Sep 23:59 | 50 | -1 | 27/100 (-2) | 10 (0) | Provisional |
Evidence behind the direction
What drives this reading?
Shares of weighted directional evidence in 12 retained current headlines. These weights already account for freshness, relevance and publisher limits; they are not additive points of the published score.
Which subjects lean each way
A subject can carry both supportive and cautious news.
SubjectCautious ← 0 → Constructive
Earnings5 stories
0.0%100.0%
Each side uses the same scale: 0–100.0% of the retained directional evidence.
Where the influence comes from
79.8%largest publisher shareA concentrated reading can depend heavily on one publisher.
Publisher groups follow the scoring rules. Company disclosures share one group; syndicated stories are consolidated before weighting.
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
66/100 tone
62.1% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
- Published
- 26 Sep 2026 02:35
- News subject
- Earnings
- Why this score
- Operating growth
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 56/100
- 30-day weight
- 62.1% of directional evidence · 3.1d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
66/100 tone
20.2% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
- Published
- 17 Sep 2026 16:19
- News subject
- Earnings
- Why this score
- Operating growth
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 48/100
- 30-day weight
- 20.2% of directional evidence · 11.5d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Tatva Chintan Pharma Chem Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 14 Sep 2026 04:38
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 15.0d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Tatva Chintan Promoters Declare No Share Encumbrance for FY26
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 13 Sep 2026 20:31
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 15.3d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
66/100 tone
11.8% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
- Published
- 13 Sep 2026 18:54
- News subject
- Earnings
- Why this score
- Operating growth
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 45/100
- 30-day weight
- 11.8% of directional evidence · 15.4d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
Capital returnNot used in direction
Tatva Chintan Pharma sets Sept 10 deadline for dividend tax docs
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 10 Sep 2026 07:00
- News subject
- Capital return
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 18.9d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
66/100 tone
4.2% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
- Published
- 06 Sep 2026 10:06
- News subject
- Earnings
- Why this score
- Operating growth
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 42/100
- 30-day weight
- 4.2% of directional evidence · 22.7d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Tatva Chintan Pharma Chem Ltd. Peer Comparison – Compare with Others
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 04 Sep 2026 07:00
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 24.9d old
- Text assessed
- Available headline and article text
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Tatva Chintan Pharma Chem Ltd. Financials – Balance Sheet, Profit & Loss, Cash Flow
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 04 Sep 2026 07:00
- News subject
- Market update
- Why this score
- Negative financial language
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 24.9d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
Market updateNot used in direction
Tatva Chintan shareholding stays anchored by promoters as institutional interest inches up
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 31 Aug 2026 16:56
- News subject
- Market update
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 28.5d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
66/100 tone
1.6% of directional evidence
Medium story strength
Scoring detailsDirect company coverage
- Published
- 30 Aug 2026 07:33
- News subject
- Earnings
- Why this score
- Operating growth
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 41/100
- 30-day weight
- 1.6% of directional evidence · 29.8d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
—Unscored
Analyst actionNot used in direction
Tatva Chintan Pharma Chem hosts analyst meet with Ventura Securities
Company news retained for context; no directional weight.
Scoring detailsDirect company coverage
- Published
- 30 Aug 2026 06:09
- News subject
- Analyst action
- Why this score
- No clear directional signal in the available text
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 29.9d old
- Text assessed
- Stored headline only
- Duplicates
- 1 consolidated
Earlier company news
TATVA news archive
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
Older news is kept in the archive
There are 32 older TATVA headlines. Open one page at a time when you need them.
Open older archiveProvider matches checked
Provider mentions not used in the score
A news provider linked these stories to TATVA, but the headline and available text are not mainly about Tatva Chintan Pharma Chem Limited. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.
Provider mentions are kept separate
Open the list to see which provider matches were checked and left out of TATVA sentiment.
Open provider mentionsHow the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme. This is a rule-based evidence measure, not a calibrated probability.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.